These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12572870)

  • 41. Nutritional Interventions in the Patient with Inflammatory Bowel Disease.
    Limketkai BN; Wolf A; Parian AM
    Gastroenterol Clin North Am; 2018 Mar; 47(1):155-177. PubMed ID: 29413010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study.
    Hedin CR; Mullard M; Sharratt E; Jansen C; Sanderson JD; Shirlaw P; Howe LC; Djemal S; Stagg AJ; Lindsay JO; Whelan K
    Inflamm Bowel Dis; 2010 Dec; 16(12):2099-108. PubMed ID: 20848469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.
    Walczuk U; Sobieszczańska B; Turniak M; Rzeszutko M; Duda-Madej A; Iwańczak B
    Adv Clin Exp Med; 2019 Jul; 28(7):899-905. PubMed ID: 31066244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
    Kump P; Högenauer C
    Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring & exploiting our 'other self' - does the microbiota hold the key to the future therapy in Crohn's?
    Haag LM; Siegmund B
    Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):399-409. PubMed ID: 24913380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of 4G-beta-D-galactosylsucrose (lactosucrose) on fecal microflora in patients with chronic inflammatory bowel disease.
    Teramoto F; Rokutan K; Kawakami Y; Fujimura Y; Uchida J; Oku K; Oka M; Yoneyama M
    J Gastroenterol; 1996 Feb; 31(1):33-9. PubMed ID: 8808426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases.
    Scarpato E; Russo M; Staiano A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S7-S9. PubMed ID: 30036240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of Escherichia coli in inflammatory bowel disease.
    Rhodes JM
    Gut; 2007 May; 56(5):610-2. PubMed ID: 17440180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial.
    Yılmaz İ; Dolar ME; Özpınar H
    Turk J Gastroenterol; 2019 Mar; 30(3):242-253. PubMed ID: 30662004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics.
    Abdelouhab K; Rafa H; Toumi R; Bouaziz S; Medjeber O; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):590-7. PubMed ID: 22211319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
    Marteau P
    Gut; 2006 Dec; 55(12):1692-3. PubMed ID: 17124152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The intestinal microbiota and its role in human health and disease.
    Kataoka K
    J Med Invest; 2016; 63(1-2):27-37. PubMed ID: 27040049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
    van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probiotics and inflammatory bowel diseases.
    Bai AP; Ouyang Q
    Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II).
    Chandran P; Satthaporn S; Robins A; Eremin O
    Surgeon; 2003 Jun; 1(3):125-36. PubMed ID: 15570747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Probiotic bacteria in the prevention and the treatment of inflammatory bowel disease.
    Fedorak R; Demeria D
    Gastroenterol Clin North Am; 2012 Dec; 41(4):821-42. PubMed ID: 23101689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.